Effects of Helicobacter pylori and protein kinase C on gene mutation in gastric cancer and precancerous lesions

陈世耀,王吉耀,纪元,张希德,朱畴文

DOI: https://doi.org/10.3969/j.issn.1009-3079.2001.03.013

2001-01-01

World Chinese Journal of Digestology

Abstract:AIM To explore the mechanism of Hp infection on the development of gastric cancer by simultaneously detecting Hp infection, PKC level, cell proliferation level and expression of p53 mutation of different gastric mucosae, from chronic gastritis, intestinal metaplasia, dysplasia and gastric cancer. METHODS A case-control study was conducted. A total of 185 cases including 52 with intestinal metaplasia (IM), 44 with dysplasia (Dys), 89 with gastric cancer (GC) and 38 control with chronic gastritis (CG) were collected in Zhongshan Hospital from Jan. 1994 to Dec. 1995. All subjects were examined by gastroendoscopy, and Hp status determined by Rapid Urease Test and pathologic Giemsa staining. Immunohistochemical assay was performed to study the expression of PKC (EnVision™), proliferating cell nuclear antigen (PCNA) and P53 protein. RESULTS The overall Hp infection rate was 76.2%(138/ 181). The rates of Hp infection were higher in IM (62.0%, 31/50), Dys (88.6%, 39/44) or GC (78.3%, 68/87) than that in CG (52.6%, 20/ 38, P<0.05). There was no significant difference of PCNA labeling index among the groups (IM, 42.0% ±26.0%, Dys, 36.5% ±28.8%, GC, 41.1% ±25.5%, CG, 35.4% ±29.7%). The index was higher in group with Hp positive than that in group with Hp negative. The expression of mutant p53 gene was higher in Dys or GC than that in IM. It was also higher in patients with Hp positive than that with Hp negative in IM group (48.5% vs 15.8%, P=0.020), but no significant difference in Dys group (53.9% vs 60.0%, P = 0.794) and GC group (53.8% vs 68.4%, P=0.258). There was a higher PCNA labeling index in patients with P53 expression than those without P53 expression. PKC expression rates were higher in IM (16.0%), Dys (28.5%) or gastric cancer (41.8%) than that in the control group (5%). PKC expression rates were higher in patients with Hp positive (36.2%) than that with Hp negative (14.6%, P=0.010). The expression rate of P53 was higher in patients with PKC positive than that in PKC negative, especially in IM group. CONCLUSION The expression levels of PCNA, PKC and p53 gene in IM, Dys and gastric cancer were higher than that in chronic gastritis. Hp infection could promote P53 mutation at the stage of intestinal metaplasia by enhancing the expression of PKC. P53 protein could be considered as the early screening indicator for gastric cancer and high-risk population like IM patients.